Vascular endothelium summary statement III: Cancer prevention and control

Eddie Reed; John Seffrin; Raffaella Giavazzi; Victor van Hinsbergh; Paolo Madeddu

doi:10.1016/j.vph.2006.10.018

Vascular endothelium summary statement III: Cancer prevention and control

Eddie Reed, John Seffrin, Raffaella Giavazzi, Victor van Hinsbergh, Paolo Madeddu

Bristol Medical School (THS)

Research output: Contribution to journal › Article (Academic Journal) › peer-review

1 Citation (Scopus)

Abstract

The biology of vascular endothelium can be modulated through the use of pharmacologic agents. Whereas this has been explored to reasonable extent in cardiovascular disease, it is clear that the ability to modulate vascular endothelium for the purpose of cancer prevention is in its early stages. Among the unanswered questions, we do not understand under what circumstances such pharmacologic interventions might best be started; nor, how long such interventions might be used for a given individual. We present concepts for further exploration in the use of endothelial-active agents for cancer prevention and control; and, strategies for public health practice and research in this area.

Translated title of the contribution	Vascular endothelium summary statement III: Cancer prevention and control
Original language	English
Pages (from-to)	321 - 323
Number of pages	3
Journal	Vascular Pharmacology
Volume	46
Issue number	5
DOIs	https://doi.org/10.1016/j.vph.2006.10.018
Publication status	Published - May 2007

Keywords

Angiogenesis Inducing Agents
Animals
Anticarcinogenic Agents
Antineoplastic Agents
Biomedical Research
Diffusion of Innovation
Endothelium, Vascular
Humans
Neoplasms
Neovascularization, Pathologic
Public Health Practice
World Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vph.2006.10.018

Handle.net

Persistent link

Cite this

@article{1748ec87ff544198b93eebe786d77147,

title = "Vascular endothelium summary statement III: Cancer prevention and control",

abstract = "The biology of vascular endothelium can be modulated through the use of pharmacologic agents. Whereas this has been explored to reasonable extent in cardiovascular disease, it is clear that the ability to modulate vascular endothelium for the purpose of cancer prevention is in its early stages. Among the unanswered questions, we do not understand under what circumstances such pharmacologic interventions might best be started; nor, how long such interventions might be used for a given individual. We present concepts for further exploration in the use of endothelial-active agents for cancer prevention and control; and, strategies for public health practice and research in this area.",

keywords = "Angiogenesis Inducing Agents, Animals, Anticarcinogenic Agents, Antineoplastic Agents, Biomedical Research, Diffusion of Innovation, Endothelium, Vascular, Humans, Neoplasms, Neovascularization, Pathologic, Public Health Practice, World Health",

author = "Eddie Reed and John Seffrin and Raffaella Giavazzi and {van Hinsbergh}, Victor and Paolo Madeddu",

year = "2007",

month = may,

doi = "10.1016/j.vph.2006.10.018",

language = "English",

volume = "46",

pages = "321 -- 323",

journal = "Vascular Pharmacology",

issn = "1537-1891",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Vascular endothelium summary statement III

T2 - Cancer prevention and control

AU - Reed, Eddie

AU - Seffrin, John

AU - Giavazzi, Raffaella

AU - van Hinsbergh, Victor

AU - Madeddu, Paolo

PY - 2007/5

Y1 - 2007/5

N2 - The biology of vascular endothelium can be modulated through the use of pharmacologic agents. Whereas this has been explored to reasonable extent in cardiovascular disease, it is clear that the ability to modulate vascular endothelium for the purpose of cancer prevention is in its early stages. Among the unanswered questions, we do not understand under what circumstances such pharmacologic interventions might best be started; nor, how long such interventions might be used for a given individual. We present concepts for further exploration in the use of endothelial-active agents for cancer prevention and control; and, strategies for public health practice and research in this area.

AB - The biology of vascular endothelium can be modulated through the use of pharmacologic agents. Whereas this has been explored to reasonable extent in cardiovascular disease, it is clear that the ability to modulate vascular endothelium for the purpose of cancer prevention is in its early stages. Among the unanswered questions, we do not understand under what circumstances such pharmacologic interventions might best be started; nor, how long such interventions might be used for a given individual. We present concepts for further exploration in the use of endothelial-active agents for cancer prevention and control; and, strategies for public health practice and research in this area.

KW - Angiogenesis Inducing Agents

KW - Animals

KW - Anticarcinogenic Agents

KW - Antineoplastic Agents

KW - Biomedical Research

KW - Diffusion of Innovation

KW - Endothelium, Vascular

KW - Humans

KW - Neoplasms

KW - Neovascularization, Pathologic

KW - Public Health Practice

KW - World Health

U2 - 10.1016/j.vph.2006.10.018

DO - 10.1016/j.vph.2006.10.018

M3 - Article (Academic Journal)

C2 - 17234459

SN - 1537-1891

VL - 46

SP - 321

EP - 323

JO - Vascular Pharmacology

JF - Vascular Pharmacology

IS - 5

ER -

Vascular endothelium summary statement III: Cancer prevention and control

Abstract

Keywords

UN SDGs

Access to Document

Handle.net

Fingerprint

Cite this